Peterborough runner says being fit helped his cancer recovery
"This will be my first and my last [London Marathon]. After this, I'll be retiring."Mr McMillan, who grew up in Adelaide, Australia, hopes his 12-year-old dog Maisie will be with him at the finish."Can I say I'm going to try to sneak Maisie onto the finish line at the London Marathon? "Perhaps, we'll see what happens - but it would be lovely to cross the finish line with Maisie because she's been such a big part of my recovery and rehabilitation."He will be raising money for the British Heart Foundation and the Royal Free Hospital in London, where he was treated.
Cancer of the neuroendocrine system - made up of nerve and gland cells that make and release hormones - can affect the stomach, bowel, pancreas and lungs.Mr McMillan aims to raise awareness of the importance of regular health checks as well as eating well and exercising.He did not notice any symptoms of his heart condition - spotted by a cancer doctor preparing him for surgery."The heart's such a complex part of the body and we just don't know what's going on inside us," he said.
Mr McMillan believes being fit helped his recovery after an operation on his liver, which was affected by the cancer."I want to get people out, getting fit and being more aware of their body," he said."That certainly helped the speediness of my recovery."I was told the recovery after the operation I had on my liver would be about eight months and luckily enough I was able to do it in about eight weeks," he said.Mr McMillan now cycles to work after an appeal to help him buy a new bike resulted in a donation from Halfords.He said his job had been "an enormous incentive for me to get well".
Follow Peterborough news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 minutes ago
- The Independent
Urgent warning issued over spread of antibiotic-resistant bacteria that could reach UK
An urgent warning has been issued over the spread of antibiotic -resistant bacteria that has the potential to reach the UK. Antimicrobial resistant bacteria is spreading rapidly among children being treated for severe malnutrition in a hospital facility in Niger, a new study has found. The researchers described the concerning findings as an 'early warning' to the world and a 'stark reminder of how fast antimicrobial resistance can spread', including to Britain. Antibiotics are life-saving medicines that are becoming ineffective due to antimicrobial resistance (AMR) – a process in which bacteria, fungi and parasites have developed the ability to resist the action of medicines. Professor Owen B Spiller, head of medical microbiology at Cardiff University and co-author of the new paper, told The Independent: 'Due to increased international travel, antibiotic-resistant bacteria can and do reach the UK. 'What we're seeing in Niger is a stark reminder of how fast antimicrobial resistance can spread when surveillance projects are under-resourced. AMR surveillance isn't just about tracking bacteria locally, it's a global early warning system. Without it, we're flying blind as these superbugs evolve and cross borders. 'The UK government needs to sustain investment in monitoring resistance, not only to protect vulnerable populations in places like Niger, but to safeguard public health here in the UK.' A UK government spokesperson said it recognises AMR as a 'major threat' and is committed to urgently tackling its spread, with progress already made, including on reducing antibiotic use in meat. Professor Spiller also said the new research on malnourished children 'provides stark evidence that humanitarian crises amplify the silent pandemic of antimicrobial resistance'. Globally, 45 million children under the age of five are estimated to be severely malnourished, according to the International Rescue Committee (IRC), with these children also at a higher risk of developing life-threatening infections like tuberculosis, or sepsis due to their weakened immune systems. There is currently a worsening starvation crisis in Gaza. Medics there say dozens have died of malnutrition in recent days as hunger sets in, after Israel cut off all supplies to the enclave for nearly three months from March-May, and restricted supplies since. Professor Spiller called on the international community to take action to prevent vulnerable children from dying from infections that should be easy to treat. He said: 'Without coordinated international action, combining antimicrobial stewardship, surveillance, and improved hygiene infrastructure, resistant bacteria will continue to spread unchecked. We urgently need global investment to safeguard antibiotics for children facing severe malnutrition in resource-limited settings.' The new study, led by the Ineos Oxford Institute for antimicrobial research (IOI) with Médecins Sans Frontières (Doctors Without Borders), involved analysing over 3,000 rectal swabs from 1,371 children under the age of five being treated for severe malnutrition between 2016 and 2017. Their findings, published in Nature Communications on Friday, showed that more than three-quarters (76 per cent) of children carried bacteria with extended-spectrum β-lactamase (ESBL) genes, which can break down many commonly used antibiotics. One in four children carried bacteria with carbapenemase genes like blaNDM, which can cause resistance to some of the most powerful and last-resort antibiotics called carbapenems. More than two-thirds (69 per cent) of children who did not carry bacteria that was resistant to this strong class of antibiotics upon admission were found to carry them when they were discharged. If antibiotic-resistant bacteria remain in the gut, these children could be at risk in the future of developing infections such as pneumonia, sepsis, diarrhoea and urinary tract infections that do not respond to antibiotic treatment, warned the researchers. Dr Kirsty Sands, scientific lead at IOI and lead author, said: 'These are some of the most vulnerable children in the world, and we're seeing them pick up bacteria that don't respond to life-saving antibiotics. 'While our study was focused in one treatment facility in Niger, this situation is likely mirrored in many more hospitals around the world. As AMR continues to increase globally, concurrent humanitarian crises such as wars and climate change are exacerbating malnutrition, leading to overcrowded treatment centres.' Dr Céline Langendorf, a lab coordinator at MSF, added: 'Our latest findings highlight the urgent need to prioritise infection prevention and control measures in hospitals to protect the most vulnerable patients. In crowded hospitals with limited resources, these bacteria can spread easily from child to child. Without urgent action, more children could die from infections that used to be easy to treat.' A UK government spokesperson said: 'Our 10 Year Health Plan recognises antimicrobial resistance (AMR) as a major threat and commits to urgently tackle its spread, including through new vaccines. "We have made important progress – reducing antibiotic use in meat and pioneering a world-first subscription model to incentivise the development of new treatments. We also continue to work closely with international partners to influence global efforts to limit the spread of AMR.' They said the government's 2024-29 UK AMR National Action Plan includes commitments to strengthen surveillance to improve the UK's capabilities to measure, predict, and mitigate the evolution and transmission of drug-resistant infections, locally, nationally and internationally. They added that the government has galvanised global support at the UN, including the agreement of a political declaration on AMR, which included targets to reduce AMR deaths by 10 per cent by 2030.
Daily Mail
3 minutes ago
- Daily Mail
Simple 14p supplement can help protect against stroke or heart attack triggering condition
A new study has revealed a simple 14p algae supplement can treat people's high blood pressure, lowering their risk of a stroke or heart attack. The researchers found edible algae like spirulina—which is available at Boots and Holland and Barrett in supplement and powder forms—lower blood pressure. The dietary supplement spirulina is a blue-green algae known for its nutritional value—as it is high in protein, iron, B vitamins and antioxidants like phycocyanin. This blue pigment comes from the presence of phycocyanin, a natural protein which supports immune, cardiovascular, liver, and brain health. Meanwhile, the green comes from chlorophyll, which also has antioxidant, detoxifying, anti‑inflammatory, and gut‑supporting effects. The findings of the study, which reviewed 29 trials with 1538 participants, were recently published in the Journal of Human Nutrition and Dietetics. The majority of trials tended focused on edible algae as supplements, but others also looked at tablets, pills, drinks and powder. Their analysis found consuming 3 grams a day of whole edible algae, especially Spirulina, for at least 12 weeks lowers blood pressure. 'This suggests that edible microalgae may serve as a natural approach to managing hypertension, complementing pharmacological treatments,' said the authors. The silent killer, high blood pressure, also called hypertension, can lead to life threatening complications like strokes or heart attacks. This is because it damages blood vessels, narrowing and stiffening them—which can result in ruptures and blockages, triggering the life-threatening events. Symptoms of high blood pressure include headaches, blurred vision, nose bleeds and chest pain. However, the British Heart Foundation has warned that most people don't realise they have high blood pressure, because the symptoms aren't obvious. So, that's why they urge people to regularly get their blood pressure checked—which is offered for free at GPs, some workplaces and many pharmacies. Classic ways to lower blood pressure include having a healthy according to the National Health Service (NHS) are, a healthy, balanced diet and regular exercise. But others include reducing salt, quitting smoking, reducing alcohol intake, and drinking less coffee. It comes as Pret A Manger recently released their vibrant blue spirulina-laced iced latte this summer. However, the coffee shop chain hasn't publicly disclosed how many grams of spirulina are in the drink. The latest study also looked at other microalgae, but spirulina was the most effective, reducing SBP by 5.28mmHg and DBP by 3.56mmHG. And you buy Cytoplan Organic Spirulina that offers 120 capsules for £16.80—it costs 14p per capsule. Systolic blood pressure (SBP) is the pressure in arteries when the heart contracts and diastolic blood pressure (DPB) is the pressure when it rests between beats. The researchers also compared microalgae like Spirulina with macroalgae like seaweeds like kelp. They found microalgae drove the most benefits with macroalgae having now significant effect. The scientists also found whole algae—the actual algae dried and eaten like spirulina powder—is more effective in lowering blood pressure. This was compared to extracts or bioactive compounds pulled out of the algae such as phycocyanin, the blue pigment. Their findings could suggest that your trendy Pret A Manger drink isn't as effective at lowering blood pressure as the spirulina whole algae supplements. While a 2022 study suggested a safe dose for adults is between three and 10 grams daily, people should not exceed the dose on the product label. Spirulina shouldn't be taken by those on blood thinners or have an autoimmune condition, bleeding disorder, allergies, or phenylketonuria (PKU)—a rare genetic disorder. Meanwhile, there is limited data on spirulina and pregnancy, so it is difficult to say whether it is safe or unsafe while someone is expecting a baby.
The Independent
32 minutes ago
- The Independent
Free STI vaccines now being offered across England
England has launched a world-first gonorrhoea vaccination programme to curb soaring infection rates and tackle the growing threat of antibiotic-resistant strains. The initiative follows a record 85,000 gonorrhoea cases in England in 2023, the highest since records began in 1918. Available free of charge from sexual health clinics, the vaccine is offered to those at highest risk, including gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine used is 4CMenB, an existing jab currently protecting against meningococcal B disease. Officials anticipate the programme will save the NHS £7.9 million over the next decade and could prevent up to 100,000 cases.
